Lyell Immunopharma Ownership | Who Owns Lyell Immunopharma?

Overview Forecast RevenueFinancials Chart

Lyell Immunopharma Ownership Summary

Lyell Immunopharma is owned by 52.44% institutional investors, 14.06% insiders, and 33.50% retail investors. Mwg management is the largest institutional shareholder, holding 7.93% of LYEL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.27% of its assets in Lyell Immunopharma shares.

LYEL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lyell Immunopharma	52.44%	14.06%	33.50%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Mwg management	20.16M	7.93%	$29.24M
Orland properties	15.09M	5.94%	$21.89M
Blackrock	13.50M	5.31%	$19.57M
Vanguard group	13.40M	5.27%	$19.43M
Foresite capital management iv	8.32M	3.27%	$12.07M
Price t rowe associates inc /md/	7.87M	3.10%	$11.42M
Wuxi apptec	7.68M	3.02%	$11.14M
Orbimed advisors	6.41M	2.52%	$9.29M
Alphabet	5.87M	2.31%	$8.50M
Geode capital management	4.01M	1.58%	$5.82M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Wuxi apptec	7.68M	47.74%	$11.14M
Mwg management	20.16M	31.93%	$29.24M
Orland properties	15.09M	16.63%	$21.89M
Foresite capital management iv	8.32M	8.11%	$12.07M
Opaleye management	1.67M	0.55%	$2.42M
Mic capital management uk llp	1.74M	0.55%	$2.52M
Alphabet	5.87M	0.43%	$8.50M
Orbimed advisors	6.41M	0.18%	$9.29M
Sc china	3.05M	0.18%	$5.00M
Ikarian capital	526.07K	0.13%	$762.80K

Top Buyers

Holder	Shares	% Assets	Change
Orbimed advisors	6.41M	0.18%	6.21M
Price t rowe associates inc /md/	7.87M	0.00%	1.14M
Balyasny asset management	985.34K	0.00%	748.58K
Ikarian capital	526.07K	0.13%	526.07K
Wellington management group llp	367.68K	0.00%	367.68K

Top Sellers

Holder	Shares	% Assets	Change
Opaleye management	1.67M	0.55%	-1.69M
Millennium management	809.56K	0.00%	-1.23M
Invenomic capital management lp	-	-	-871.52K
Massachusetts financial services co /ma/	-	-	-577.32K
Jpmorgan chase	97.14K	-	-557.48K

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	526.07K	0.13%	526.07K	$762.80K
Wellington management group llp	367.68K	0.00%	367.68K	$533.13K
Mirae asset global etfs	312.41K	0.00%	312.41K	$452.99K
Boothbay fund management	139.88K	0.00%	139.88K	$202.83K
Corebridge financial	86.45K	0.00%	86.45K	$125.36K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-34.00
Rothschild investment	-50.00
Riggs asset managment	-150.00
Tyler-stone wealth management	-850.00
Metropolitan life insurance co/ny	-6.62K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	116	-5.69%	133,324,052	0.44%	52	1.91%	49	-14.04%	43	-2.27%
Mar 31, 2024	123	5.13%	132,733,881	1.13%	52	1.92%	57	-1.72%	44	46.67%
Dec 31, 2023	117	12.50%	131,255,797	7.18%	52	2.18%	58	-4.92%	30	42.86%
Sep 30, 2023	104	5.05%	122,457,371	0.23%	48	2.04%	61	32.61%	21	-38.24%
Jun 30, 2023	99	1.02%	122,180,099	3.79%	48	2.20%	46	-6.12%	34	41.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.82M	2.27%	-
T. Rowe Price Health Sciences	5.40M	2.11%	-107.67K
iShares Russell 2000 ETF	4.29M	1.67%	-9.63K
Biotech Growth Ord	2.88M	1.12%	-
Vanguard Institutional Extnd Mkt Idx Tr	2.52M	0.98%	-2.41K
Vanguard Small Cap Index	2.24M	0.87%	5.37K
Fidelity Small Cap Index	1.65M	0.64%	-36.10K
iShares Russell 2000 Value ETF	1.55M	0.60%	-
Vanguard Small Cap Growth Index Inv	1.25M	0.49%	-5.54K
State St Russell Sm/Mid Cp® Indx NL Cl C	1.19M	0.47%	-33.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 15, 2023	Klausner Richard	-	Sell	$132.29K
Jun 21, 2021	FRIEDMAN CATHY	-	Buy	$300.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2023 Q4	-	-
2023 Q3	-	1
2023 Q2	-	-
2023 Q1	-	-

LYEL Ownership FAQ

Who Owns Lyell Immunopharma?

Lyell Immunopharma shareholders are primarily institutional investors at 52.44%, followed by 14.06% insiders and 33.50% retail investors. The average institutional ownership in Lyell Immunopharma's industry, Biotech Stocks , is 44.97%, which Lyell Immunopharma exceeds.

Who owns the most shares of Lyell Immunopharma?

Lyell Immunopharma’s largest shareholders are Mwg management (20.16M shares, 7.93%), Orland properties (15.09M shares, 5.94%), and Blackrock (13.5M shares, 5.31%). Together, they hold 19.17% of Lyell Immunopharma’s total shares outstanding.

Does Blackrock own Lyell Immunopharma?

Yes, BlackRock owns 5.31% of Lyell Immunopharma, totaling 13.5M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 19.57M$. In the last quarter, BlackRock decreased its holdings by -397K shares, a -2.86% change.

Who is Lyell Immunopharma’s biggest shareholder by percentage of total assets invested?

Wuxi apptec is Lyell Immunopharma’s biggest shareholder by percentage of total assets invested, with 47.74% of its assets in 7.68M Lyell Immunopharma shares, valued at 11.14M$.

Who is the top mutual fund holder of Lyell Immunopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lyell Immunopharma shares, with 2.27% of its total shares outstanding invested in 5.82M Lyell Immunopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools